$OFIX
Orthofix Medical Inc.

2015 Q1 Form 10-Q Financial Statement

#000156459015004472 Filed on May 18, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q1
Revenue $89.76M $100.0M
YoY Change -10.25% -2.21%
Cost Of Revenue $19.34M $26.77M
YoY Change -27.77% 3.61%
Gross Profit $70.42M $73.24M
YoY Change -3.85% -4.18%
Gross Profit Margin 78.46% 73.23%
Selling, General & Admin $65.85M $61.42M
YoY Change 7.23% -3.1%
% of Gross Profit 93.51% 83.85%
Research & Development $5.845M $5.939M
YoY Change -1.58% 3.45%
% of Gross Profit 8.3% 8.11%
Depreciation & Amortization $400.0K $6.004M
YoY Change -93.34% 19.39%
% of Gross Profit 0.57% 8.2%
Operating Expenses $77.62M $73.27M
YoY Change 5.93% 4.12%
Operating Profit -$7.192M -$29.00K
YoY Change 24700.0% -100.48%
Interest Expense $272.0K $468.0K
YoY Change -41.88% -16.43%
% of Operating Profit
Other Income/Expense, Net $419.0K -$740.0K
YoY Change -156.62% -117.6%
Pretax Income -$6.773M -$769.0K
YoY Change 780.75% -106.26%
Income Tax $964.0K $1.179M
% Of Pretax Income
Net Earnings -$8.379M -$2.508M
YoY Change 234.09% -172.76%
Net Earnings / Revenue -9.33% -2.51%
Basic Earnings Per Share -$0.45 -$0.14
Diluted Earnings Per Share -$0.45 -$0.14
COMMON SHARES
Basic Shares Outstanding 18.73M 18.20M
Diluted Shares Outstanding 18.73M 18.20M

Balance Sheet

Concept 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $29.80M $25.10M
YoY Change 18.73% -25.52%
Cash & Equivalents $29.78M $25.12M
Short-Term Investments
Other Short-Term Assets $90.00M $90.40M
YoY Change -0.44% 14.43%
Inventory $56.70M $92.75M
Prepaid Expenses
Receivables $58.50M $76.92M
Other Receivables $0.00 $0.00
Total Short-Term Assets $235.0M $278.4M
YoY Change -15.6% -17.44%
LONG-TERM ASSETS
Property, Plant & Equipment $46.70M $52.53M
YoY Change -11.1% 0.25%
Goodwill $53.57M
YoY Change -26.23%
Intangibles $8.518M
YoY Change 25.91%
Long-Term Investments
YoY Change
Other Assets $45.50M $6.743M
YoY Change 574.77% -52.36%
Total Long-Term Assets $151.7M $125.5M
YoY Change 20.83% -1.06%
TOTAL ASSETS
Total Short-Term Assets $235.0M $278.4M
Total Long-Term Assets $151.7M $125.5M
Total Assets $386.7M $404.0M
YoY Change -4.28% -12.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.30M $14.00M
YoY Change 16.43% -1.41%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $69.40M $55.49M
YoY Change 25.07% -15.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $20.00M
YoY Change -100.0% 0.0%
Other Long-Term Liabilities $26.80M $12.49M
YoY Change 114.62% 195.41%
Total Long-Term Liabilities $26.80M $12.49M
YoY Change 114.62% 195.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $69.40M $55.49M
Total Long-Term Liabilities $26.80M $12.49M
Total Liabilities $96.20M $103.4M
YoY Change -6.97% 0.22%
SHAREHOLDERS EQUITY
Retained Earnings $88.55M
YoY Change -41.23%
Common Stock $225.5M
YoY Change -10.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $290.5M $300.6M
YoY Change
Total Liabilities & Shareholders Equity $386.7M $404.0M
YoY Change -4.28% -12.97%

Cashflow Statement

Concept 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$8.379M -$2.508M
YoY Change 234.09% -172.76%
Depreciation, Depletion And Amortization $400.0K $6.004M
YoY Change -93.34% 19.39%
Cash From Operating Activities $2.543M -$10.20M
YoY Change -124.93% -167.55%
INVESTING ACTIVITIES
Capital Expenditures $5.074M $3.691M
YoY Change 37.47% -38.78%
Acquisitions
YoY Change
Other Investing Activities -$10.50M $0.00
YoY Change
Cash From Investing Activities -$15.56M -$3.700M
YoY Change 320.62% -39.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.710M $5.542M
YoY Change -69.14% 158.61%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.938M 10.10M
YoY Change -11.5% -271.19%
NET CHANGE
Cash From Operating Activities 2.543M -10.20M
Cash From Investing Activities -15.56M -3.700M
Cash From Financing Activities 8.938M 10.10M
Net Change In Cash -4.082M -3.800M
YoY Change 7.42% -222.58%
FREE CASH FLOW
Cash From Operating Activities $2.543M -$10.20M
Capital Expenditures $5.074M $3.691M
Free Cash Flow -$2.531M -$13.89M
YoY Change -81.78% -253.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-2508000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
61358000
CY2014Q4 us-gaap Inventory Net
InventoryNet
59846000
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
89762000
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
100014000
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-272000
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
34424000
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
37413000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
229000
CY2015Q1 ofix Market Service Revenue
MarketServiceRevenue
12930000
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5845000
CY2015Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
405000
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
584000
CY2015Q1 ofix Accounting Review And Restatement Costs
AccountingReviewAndRestatementCosts
5916000
CY2014Q1 ofix Accounting Review And Restatement Costs
AccountingReviewAndRestatementCosts
8306000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
77615000
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
73270000
CY2015Q1 us-gaap Interest Expense
InterestExpense
272000
CY2014Q1 us-gaap Interest Expense
InterestExpense
468000
CY2014Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
26773000
CY2015Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-139000
CY2015Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.04
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.03
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2015Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.41
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.11
CY2015Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.04
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.03
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
691000
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
419000
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-740000
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6773000
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-769000
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
964000
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1179000
CY2015Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-7737000
CY2014Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1948000
CY2015Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-781000
CY2014Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-794000
CY2014Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-234000
CY2015Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-642000
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-560000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-8379000
CY2015Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.41
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.11
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18731985
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18197363
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18731985
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18197363
CY2015Q1 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
665000
CY2014Q1 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
103000
CY2015Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4860000
CY2014Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
376000
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12574000
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2029000
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
4941000
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-10212000
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5074000
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3691000
CY2015Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
39000
CY2014Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
46000
CY2015Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
4800000
CY2015Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
15250000
CY2014Q1 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
32000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-15563000
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3705000
CY2015Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1710000
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5542000
CY2015Q1 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
7171000
CY2014Q1 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
4502000
CY2015Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
57000
CY2014Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
29000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
8938000
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
10073000
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-5347000
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
37000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7031000
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3807000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28924000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25117000
CY2015Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
4
CY2015Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3868000
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3879000
CY2015Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4441000
CY2014Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4830000
CY2015Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
42445000
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
45612000
CY2015Q1 ofix Deferred Cost Of Sales Net Of Reserves
DeferredCostOfSalesNetOfReserves
5955000
CY2014Q4 ofix Deferred Cost Of Sales Net Of Reserves
DeferredCostOfSalesNetOfReserves
5525000
CY2015Q1 ofix Line Of Credit Facility Maximum Potential Decrease To Borrowing Capacity
LineOfCreditFacilityMaximumPotentialDecreaseToBorrowingCapacity
100000000
CY2015Q1 us-gaap Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
184100000
CY2014Q4 us-gaap Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
181800000
CY2015Q1 us-gaap Line Of Credit
LineOfCredit
0
CY2015Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
6200000
CY2014Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
5800000
CY2014Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
7000000
CY2015Q1 us-gaap Derivative Instruments Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing
DerivativeInstrumentsLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTesting
3000000
CY2014Q1 us-gaap Derivative Instruments Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing
DerivativeInstrumentsLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTesting
100000
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1777000
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1187000
CY2015Q1 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
153367
CY2014Q1 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
263575
CY2015Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.142
CY2014Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.533
CY2015Q1 ofix Effective Income Tax Rate Continuing Operations Excluding Impact Of Tax Settlement
EffectiveIncomeTaxRateContinuingOperationsExcludingImpactOfTaxSettlement
-0.092
CY2014Q1 ofix Effective Income Tax Rate Continuing Operations Excluding Impact Of Tax Settlement
EffectiveIncomeTaxRateContinuingOperationsExcludingImpactOfTaxSettlement
-0.685
CY2015Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
15600000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
15600000
CY2015Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
500000
CY2014Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
500000
CY2015Q1 ofix Number Of Strategic Business Units
NumberOfStrategicBusinessUnits
4
CY2015Q1 ofix Percentage Of Reported Increase Decrease
PercentageOfReportedIncreaseDecrease
-0.10
CY2015Q1 ofix Percentage Of Constant Currency Increase Decrease
PercentageOfConstantCurrencyIncreaseDecrease
-0.07
CY2015Q1 ofix Net Margin
NetMargin
26138000
CY2014Q1 ofix Net Margin
NetMargin
32070000

Files In Submission

Name View Source Status
0001564590-15-004472-index-headers.html Edgar Link pending
0001564590-15-004472-index.html Edgar Link pending
0001564590-15-004472.txt Edgar Link pending
0001564590-15-004472-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ofix-10q_20150331.htm Edgar Link pending
ofix-20150331.xml Edgar Link completed
ofix-20150331.xsd Edgar Link pending
ofix-20150331_cal.xml Edgar Link unprocessable
ofix-20150331_def.xml Edgar Link unprocessable
ofix-20150331_lab.xml Edgar Link unprocessable
ofix-20150331_pre.xml Edgar Link unprocessable
ofix-ex311_201503317.htm Edgar Link pending
ofix-ex312_201503319.htm Edgar Link pending
ofix-ex321_201503318.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending